These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 850579)

  • 1. Single agent vs combination chemotherapy in the treatment of ovarian cancer.
    Barlow JJ; Piver MS
    Obstet Gynecol; 1977 May; 49(5):609-11. PubMed ID: 850579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy in ovarian carcinoma recurrent after radiation therapy.
    Lele SB; Piver MS; Barlow JJ
    Obstet Gynecol; 1978 Jan; 51(1):101-4. PubMed ID: 619324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy in advanced ovarian cancer.
    Smith JP; Rutledge FN
    Natl Cancer Inst Monogr; 1975 Oct; 42():141-3. PubMed ID: 825776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of the Gynecologic Oncology Group trials on ovarian cancer: preliminary report.
    Hreshchyshyn MM
    Natl Cancer Inst Monogr; 1975 Oct; 42():155-65. PubMed ID: 1234633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary treatment of advanced ovarian adenocarcinoma, stages III and IV.
    Piver S; Barlow JJ; Chung WS; Lee FT; Vongtama V
    Natl Cancer Inst Monogr; 1975 Oct; 42():177-82. PubMed ID: 825780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy in advanced ovarian carcinoma: current standards of care based on randomized trials.
    Thigpen T; Vance R; Puneky L; Khansur T
    Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S97-107. PubMed ID: 7835816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878.
    Wadler S; Yeap B; Vogl S; Carbone P
    Cancer; 1996 Feb; 77(4):733-42. PubMed ID: 8616766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced ovarian adenocarcinoma. A prospective clinical trial of melphalan (L-PAM) versus combination chemotherapy.
    Young RC; Chabner BA; Hubbard SP; Fisher RI; Bender RA; Anderson T; Simon RM; Canellos GP; DeVita VT
    N Engl J Med; 1978 Dec; 299(23):1261-6. PubMed ID: 101843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preliminary Results of trials of chemotherapy in advanced ovarian carcinoma.
    Young RC; Chabner BA; Hubbard SP; Canellos GP; DeVita VT
    Natl Cancer Inst Monogr; 1975 Oct; 42():145-8. PubMed ID: 825777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endodermal sinus tumor: a report of two sustained remissions treated postoperatively with a combination of actinomycin D, 5-fluorouracil, and cyclophosphamide.
    Forney JP; Di Saia PJ; Morrow CP
    Obstet Gynecol; 1975 Feb; 45(2):186-9. PubMed ID: 1118091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Advanced epithelial cancers of the ovary: results of 4 chemotherapy protocols (110 cases)].
    Israël L; Lepage E; Breau JL; Aguilera J
    Bull Cancer; 1982; 69(5):426-33. PubMed ID: 6891902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quadrichemotherapy for advanced ovarian carcinoma.
    Kessinger A; Foley JF; Lemon HM
    Obstet Gynecol; 1976 Aug; 48(2):134-6. PubMed ID: 940644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy of ovarian cancer. New approaches to treatment.
    Smith JP; Rutledge F; Wharton JT
    Cancer; 1972 Dec; 30(6):1565-71. PubMed ID: 4345098
    [No Abstract]   [Full Text] [Related]  

  • 14. Chemotherapy of ovarian cancer.
    Dimitriades M; Papadimitriou GC; Razis DV; Panopoulos C; Midoulas N
    Int Surg; 1978 Feb; 63(2):81-3. PubMed ID: 632023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Random study of hexamethylmelamine, 5-fluorouracil, and melphalan in treatment of advanced carcinoma of the ovary.
    Smith JP; Rutledge FN
    Natl Cancer Inst Monogr; 1975 Oct; 42():169-72. PubMed ID: 825778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histologic grade in advanced ovarian cancer.
    Ozols RF; Garvin AJ; Costa J; Simon RM; Young RC
    Cancer Treat Rep; 1979 Feb; 63(2):255-63. PubMed ID: 109199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy of ovarian cancer: past and present.
    Young RC
    Semin Oncol; 1975 Sep; 2(3):267-76. PubMed ID: 827024
    [No Abstract]   [Full Text] [Related]  

  • 18. Combination v. sequential therapy with melphalan, 5-fluorouracil and methotrexate for advanced ovarian cancer.
    Miller AB; Klaassen DJ; Boyes DA; Dodds DJ; Gerulath A; Kirk ME; Levitt M; Pearson JG; Wall C
    Can Med Assoc J; 1980 Sep; 123(5):365-71. PubMed ID: 7020903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of women with disseminated or recurrent advanced ovarian cancer with melphalan alone in combination with 5-fluorouracil and dactinomycin or with the combination of cytoxan, 5-fluorouracil and dactinomycin.
    Park RC; Blom J; Disaia PJ; Lagasse LD; Blessing JA
    Cancer; 1980 May; 45(10):2529-42. PubMed ID: 7378989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclophosphamide plus cis-platinum in combination: treatment program for stage III or IV ovarian carcinoma.
    Decker DG; Fleming TR; Malkasian GD; Webb MJ; Jeffries JA; Edmonson JH
    Obstet Gynecol; 1982 Oct; 60(4):481-7. PubMed ID: 6889714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.